Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Hepatitis C screening

Ruth E. Dubin, Andrea Furlan and Sanjeev Arora
CMAJ February 17, 2015 187 (3) 208; DOI: https://doi.org/10.1503/cmaj.115-0012
Ruth E. Dubin
Department of Medicine (Dubin), Queen’s University, Kingston, Ont.; Department of Medicine (Furlan), University of Toronto, Toronto, Ont.; ECHO Institute (Arora), University of New Mexico School of Medicine, Albuquerque, NM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Furlan
Department of Medicine (Dubin), Queen’s University, Kingston, Ont.; Department of Medicine (Furlan), University of Toronto, Toronto, Ont.; ECHO Institute (Arora), University of New Mexico School of Medicine, Albuquerque, NM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeev Arora
Department of Medicine (Dubin), Queen’s University, Kingston, Ont.; Department of Medicine (Furlan), University of Toronto, Toronto, Ont.; ECHO Institute (Arora), University of New Mexico School of Medicine, Albuquerque, NM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

In a CMAJ news article, Fralick1 reports that it is unclear how Canadian hepatologists, who can barely manage their current caseloads, will be able to meet the inevitable increased demand for care created by wider screening.

Project ECHO (Extension for Community Healthcare Outcomes) was developed in 2003 by Dr. Sanjeev Arora, a hepatologist at the University of New Mexico, in Albuquerque, to address this problem via weekly video clinics with widely dispersed primary care providers. Case discussions and didactic lectures support the provision of evidence-based treatments in patients’ hometowns.

This learning-by-doing model led to an increase in the number of patients in New Mexico who were cured of hepatitis C. Clinical outcomes of patients treated in the community matched those outcomes achieved in the University setting.2 Those cured of hepatitis C have been shown to have had a 93% reduction in liver-related mortality and a 74% reduction in 10-year all-cause mortality.3 Liver cancer rates declined by 76%.3 Effective treatment results in a reduction in costly liver transplants and management of liver cancer.

Access to treatments for addiction has increased via the Integrated Addictions and Psychiatry TeleECHO Clinic. ECHO-linked primary care providers offer vaccination for hepatitis A and B and education on prevention, alcohol cessation, hepatotoxic drug avoidance and nicotine and marijuana cessation to reduce rates of liver fibrosis.

By providing primary care providers with the skills and the support to practise at the highest level of their competence, ECHO can redress geographic imbalances in access to specialist care. The ECHO model also leads to rapid dissemination of best practices, increased primary care provider satisfaction and self-efficacy in managing complex chronic diseases, and improved patient outcomes.4

References

  1. ↵
    1. Fralick M
    . Screening urged for hepatitis C but drug costs are prohibitive. CMAJ 2014;186:329.
    OpenUrlFREE Full Text
  2. ↵
    1. Arora S,
    2. Thornton K,
    3. Murata G,
    4. et al
    . Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011;364:2199–207.
    OpenUrlCrossRefPubMed
  3. ↵
    1. van der Meer AJ,
    2. Veldt BJ,
    3. Feld JJ,
    4. et al
    . Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012;308:2584–93.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Arora S,
    2. Kalishman S,
    3. Dion D,
    4. et al
    . QUALITY PROFILE: Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care. Health Aff 2011;30:1176–84.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (3)
CMAJ
Vol. 187, Issue 3
17 Feb 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hepatitis C screening
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hepatitis C screening
Ruth E. Dubin, Andrea Furlan, Sanjeev Arora
CMAJ Feb 2015, 187 (3) 208; DOI: 10.1503/cmaj.115-0012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Hepatitis C screening
Ruth E. Dubin, Andrea Furlan, Sanjeev Arora
CMAJ Feb 2015, 187 (3) 208; DOI: 10.1503/cmaj.115-0012
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Coexisting failures do not diminish the stature of a giant
  • Dare we hope
  • Highlighting obesity as a risk factor for endometrial cancer
Show more Letters

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire